allogene
Allogene Therapeutics is seeking a Senior Associate Scientist to develop and characterize clinical-scale manufacturing processes for CAR T cell therapies. The role involves executing design of experiments, supporting non‑GMP manufacturing, documenting work, and contributing to regulatory filings and project teams.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2017
Allogene is a clinical-stage biotechnology company developing off-the-shelf AlloCAR T cell therapies using multiplex gene engineering and gene-editing to create allogeneic (ready-made) CAR T candidates. The company pairs a proprietary lymphodepletion approach with scalable, state-of-the-art manufacturing to optimize safety, durability, and broader patient access. Lead programs include cemacabtagene ansegedleucel (cema‑cel) for large B‑cell lymphoma (including frontline DLBCL), ALLO‑316 for renal cell carcinoma, and ALLO‑329 for autoimmune disease, alongside a broader pipeline. Allogene’s platform strategy aims to accelerate delivery of cell therapies by removing patient-specific manufacturing constraints.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for allogene.
31% below the average for this role
Scientist, Cell Therapy
BeOne Medicines
Principal Scientist, Engineered Cell Therapy Discovery
Bristol Myers Squibb
Scientist, In Vivo CAR-T
Legend Biotech
Bench Scientist
Global Channel Management
Ceel & Gene Therapy Technical Development
Global Channel Management
Senior Associate Scientist - Discovery Research, Regeneron Cell Medicines
Regeneron Pharmaceuticals